Healthcare provider profile · identity verified

Bruce M Kaplan, MD

Internal Medicine · SOUTHFIELD, MI · NPI 1548271208

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Oxycodone Hcl	Oxycodone Hcl	641	153
Ibuprofen	Ibuprofen	547	140
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	362	95
Naloxone Hcl	Naloxone Hcl	360	117
Famotidine	Famotidine	356	80
Diclofenac Sodium	Diclofenac Sodium	333	74
Albuterol Sulfate Hfa	Albuterol Sulfate	277	70
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	265	86
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	188	63
Omeprazole	Omeprazole	169	39
Gabapentin	Gabapentin	162	46
Fluticasone Propionate	Fluticasone Propionate	159	26
Lisinopril	Lisinopril	133	31
Atorvastatin Calcium	Atorvastatin Calcium	131	27
Amlodipine Besylate	Amlodipine Besylate	130	36
Baclofen	Baclofen	127	25
Naproxen	Naproxen	123	39
Esomeprazole Magnesium	Esomeprazole Magnesium	122	23
Lidocaine	Lidocaine	114	31
Montelukast Sodium	Montelukast Sodium	102	18
Tizanidine Hcl	Tizanidine Hcl	90	15
Carvedilol	Carvedilol	86	23
Duloxetine Hcl	Duloxetine Hcl	84	17
Desipramine Hcl	Desipramine Hcl	78	15
Linzess	Linaclotide	69	17
Clonidine Hcl	Clonidine Hcl	68	11
Trazodone Hcl	Trazodone Hcl	63	11
Diclofenac Sodium Er	Diclofenac Sodium	59	suppressed
Celecoxib	Celecoxib	54	13
Lidocaine-Prilocaine	Lidocaine/Prilocaine	52	suppressed
Lansoprazole	Lansoprazole	51	12
Ibu	Ibuprofen	50	21
Breo Ellipta	Fluticasone/Vilanterol	48	suppressed
Furosemide	Furosemide	48	11
Halobetasol Propionate	Halobetasol Propionate	48	suppressed
Clobetasol Propionate	Clobetasol Propionate	45	12
Losartan Potassium	Losartan Potassium	44	suppressed
Metformin Hcl	Metformin Hcl	44	suppressed
Ventolin Hfa	Albuterol Sulfate	44	17
Pregabalin	Pregabalin	43	suppressed
Azelastine Hcl	Azelastine Hcl	41	suppressed
Prednisone	Prednisone	41	suppressed
Ondansetron Odt	Ondansetron	39	suppressed
Varenicline Tartrate	Varenicline Tartrate	38	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	37	suppressed
Simvastatin	Simvastatin	37	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	36	suppressed
Diclofenac Sodium-Misoprostol	Diclofenac Sodium/Misoprostol	34	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	suppressed
Metoprolol Succinate	Metoprolol Succinate	33	suppressed
Dexlansoprazole Dr	Dexlansoprazole	30	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Ketoconazole	Ketoconazole	27	suppressed
Naproxen Sodium	Naproxen Sodium	27	suppressed
Potassium Chloride	Potassium Chloride	26	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	25	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Metronidazole	Metronidazole	24	suppressed
Nifedipine Er	Nifedipine	23	suppressed
Ammonium Lactate	Ammonium Lactate	22	suppressed
Etodolac Er	Etodolac	22	suppressed
Methocarbamol	Methocarbamol	22	suppressed
Methylprednisolone	Methylprednisolone	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Lubiprostone	Lubiprostone	21	suppressed
Verapamil Hcl	Verapamil Hcl	21	suppressed
Erythromycin-Benzoyl Peroxide	Erythromycin/Benzoyl Peroxide	20	suppressed
Fluconazole	Fluconazole	20	suppressed
Procto-Med Hc	Hydrocortisone	20	suppressed
Fluocinonide	Fluocinonide	19	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	19	suppressed
Betamethasone Valerate	Betamethasone Valerate	18	suppressed
Megestrol Acetate	Megestrol Acetate	18	suppressed
Allopurinol	Allopurinol	17	suppressed
Cilostazol	Cilostazol	17	suppressed
Desloratadine	Desloratadine	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	suppressed
Levothyroxine Sodium	Levothyroxine Sodium	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Etodolac	Etodolac	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Chlorzoxazone	Chlorzoxazone	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Azithromycin	Azithromycin	13	suppressed
Imipramine Pamoate	Imipramine Pamoate	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Meloxicam	Meloxicam	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Diflorasone Diacetate	Diflorasone Diacetate	12	suppressed
Enulose	Lactulose	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	12	suppressed
Teriflunomide	Teriflunomide	12	suppressed
Clopidogrel	Clopidogrel Bisulfate	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Lactulose	Lactulose	11	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error